SCHEMBL5485748

SCHEMBL5485748

CCCN(C(=O)C1CCC1)c1ccc2oc(N(Cc3ccc(OC)c(OCC)c3)C3CCNCC3)nc2c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SSTR5 P35346 10/20 0.41
HRH1 P35367 4/20 0.41
SSTR1 P30872 1/20 0.41
REN P00797 3/20 0.39
KCNH2 Q12809 2/20 0.38
HDAC6 Q9UBN7 1/20 0.38
LMNA P02545 2/20 0.35
MAPT P10636 2/20 0.35
THRB P10828 1/20 0.35
NR1H4 Q96RI1 4/20 0.34
HTR2B P41595 1/20 0.34
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5485903 0.82 HDAC6 (0.46) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL5485744 0.81 SSTR5 (0.49) SSTR5HRH1SSTR1RENHDAC6
SCHEMBL5484863 0.80 SSTR5 (0.57) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL4594763 0.80 SSTR5 (0.41) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL4594185 0.80 SSTR5 (0.42) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL1379151 0.79 SSTR5 (0.56) SSTR5HRH1SSTR1KCNH2HDAC6
SCHEMBL4593246 0.79 SSTR5 (0.41) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL4593310 0.79 REN (0.41) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL4594457 0.78 SSTR5 (0.39) SSTR5HRH1SSTR1RENKCNH2
SCHEMBL5485488 0.78 SSTR5 (0.57) SSTR5HRH1SSTR1KCNH2HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1858901-A1 BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS F. Hoffmann-La Roche AG (CH) 2007-11-28 EP disclosed
WO-2006094682-A1 BENZOTHIAZOLE, THIAZOLOPYRIDINE, BENZOOXAZOLE AND OXAZOLOPYRIDINE DERIVATIVES AS ANTIDIABETIC COMPOUNDS F. HOFFMANN-LA ROCHE AG (CH) 2006-09-14 WO disclosed